Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic International Normalized Ratio is not due to inflammation

British Journal of Haematology

Volumn 142, Issue 6, 2008, Pages 946-952

  Gatt, A ^a,b   Van Veen, J J ^b   Bowyer, A ^b   Woolley, A M ^b   Cooper, P ^b   Kitchen, S ^b   Makris, M ^b  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Atrial fibrillation; International Normalized Ratio; Thrombin generation; Warfarin

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; C REACTIVE PROTEIN; FIBRINOGEN; PROTHROMBIN; THROMBIN; VON WILLEBRAND FACTOR;

AGED; ANALYTICAL EQUIPMENT; ANTICOAGULATION; ARTICLE; AUTOANALYSIS; CORRELATION ANALYSIS; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INFLAMMATION; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBIN TIME; THROMBOGRAM;

ADULT; AGED; ATRIAL FIBRILLATION; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; COHORT STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INFLAMMATION; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; PROTHROMBIN; REFERENCE VALUES; THROMBIN;

EID: 50049111131     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07279.x     Document Type: Article

References (22)

1. Asakura, H., Hifumi, S., Jokaji, H., Saito, M., Kumabashiri, I., Uotani, C., Morishita, E., Yamazaki, M., Shibata, K., Mizuhashi, K., Mifune, J. Matsuda, T. (1992) Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation. Blood Coagulation and Fibrinolysis, 3, 469 473.
2. Boos, C.J. Lip, G.Y. (2008) Inflammation and atrial fibrillation: cause or effect? Heart, 94, 133 134.
3. Boos, C.J., Anderson, R.A. Lip, G.Y. (2006) Is atrial fibrillation an inflammatory disorder? European Heart Journal, 27, 136 149.
4. Bozic, M. Stegnar, M. (2003) Validation of an automated immunoturbidimetric assay for measurement of plasma D-dimer. Clinical Chemistry and Laboratory Medicine, 41, 958 962.
5. Bruner, Jr., K.W. Kissling, C.W. (1980) Evaluation of a pneumatic-tube system for delivery of blood specimens to the blood bank. American Journal of Clinical Pathology, 73, 593 596.
6. Clauss, A. (1957) Rapid physiological coagulation method in determination of fibrinogen. Acta Haematologica, 17, 237 246.
7. Dyszkiewicz-Korpanty, A., Quinton, R., Yassine, J. Sarode, R. (2004) The effect of a pneumatic tube transport system on PFA-100 trade mark closure time and whole blood platelet aggregation. Journal of Thrombosis and Haemostasis, 2, 354 356.
8. Gage, B.F., Waterman, A.D., Shannon, W., Boechler, M., Rich, M.W. Radford, M.J. (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA: The Journal of the American Medical Association, 285, 2864 2870.
9. Gullov, A.L., Koefoed, B.G., Petersen, P., Pedersen, T.S., Andersen, E.D., Godtfredsen, J. Boysen, G. (1998) Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study. Archives of Internal Medicine, 158, 1513 1521.
10. Hart, R.G., Benavente, O., McBride, R. Pearce, L.A. (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Annals of Internal Medicine, 131, 492 501.
11. Hellemons, B.S., Langenberg, M., Lodder, J., Vermeer, F., Schouten, H.J., Lemmens, T., van Ree, J.W. Knottnerus, J.A. (1999) Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin. BMJ, 319, 958 964.
12. Hemker, H.C., Giesen, P., Al Dieri, R., Regnault, V., de Smedt, E., Wagenvoord, R., Lecompte, T. Beguin, S. (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiology of Haemostasis and Thrombosis, 33, 4 15.
13. Jackson, C.M., Esnouf, M.P. Lindahl, T.L. (2003) A critical evaluation of the prothrombin time for monitoring oral anticoagulant therapy. Pathophysiology of Haemostasis and Thrombosis, 33, 43 51.
14. Koster, T., Blann, A.D., Briet, E., Vandenbroucke, J.P. Rosendaal, F.R. (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet, 345, 152 155.
15. Medi, C., Hankey, G.J. Freedman, S.B. (2007) Atrial fibrillation. Medical Journal of Australia, 186, 197 202.
16. Noe, D.A., Murphy, P.A., Bell, W.R. Siegel, J.N. (1989) Acute-phase behavior of factor VIII procoagulant and other acute-phase reactants in rabbits. American Journal of Physiology, 257, R49 R56.
17. O'Donnell, J., Mumford, A.D., Manning, R.A. Laffan, M.A. (2001) Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism. British Journal of Haematology, 115, 687 691.
18. Petersen, P., Boysen, G., Godtfredsen, J., Andersen, E.D. Andersen, B. (1989) Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet, 1, 175 179.
19. Pragay, D.A., Fan, P., Brinkley, S. Chilcote, M.E. (1980) A computer directed pneumatic tube system: its effects on specimens. Clinical Biochemistry, 13, 259 261.
20. Short, P.E., Williams, C.E., Picken, A.M. Hill, F.G. (1982) Factor VIII related antigen: an improved enzyme immunoassay. Medical Laboratory Sciences, 39, 351 355.
21. The Stroke Prevention in Atrial Fibrillation Investigators (1996) Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: stroke prevention in Atrial fibrillation III randomised clinical trial. Lancet, 348, 633 638.
22. van Walraven, C., Hart, R.G., Singer, D.E., Koudstaal, P.J. Connolly, S. (2003) Oral anticoagulants vs. aspirin for stroke prevention in patients with non-valvular atrial fibrillation: the verdict is in. Cardiac Electrophysiology Review, 7, 374 378.